Latest filing published 14 Feb 2025 for Sage Therapeutics, Inc., €4,733.
Insider track record
No signal scores available.
Laura Gault: trading record in brief
Laura Gault appears in our data through filings on Sage Therapeutics, Inc. shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 13 February 2024 and the latest from 13 February 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 14 February 2025 came the latest disclosure, a share grant for €4,733 in Sage Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Laura Gault
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 685 shares@ US$7.18100.0% of flowCommon StockSEC:0001562180-25-001201:0
- 24,000 shares0Common StockSEC:0001562180-25-000436:0
- 3,288 shares@ US$8.96Common StockSEC:0001562180-24-006089:1
- 13,500 shares0Common StockSEC:0001562180-24-006089:0
- 11,250 shares0Common StockSEC:0001562180-24-001337:0
5 of 5 declarations
